On the relationship between (3H)choline uptake activation and (3H)acetylcholine release.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001464:Barium / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002794:Choline / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D010830:Physostigmine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D013324:Strontium / Q000494:pharmacology; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism*; D013779:Tetrodotoxin / Q000494:pharmacology; D014701:Veratridine / Q000494:pharmacology; D014747:Vinblastine / Q000494:pharmacology
D001464:Barium; D013779:Tetrodotoxin; D014747:Vinblastine; D014701:Veratridine; D012964:Sodium; D010830:Physostigmine; D008274:Magnesium; D002794:Choline; D000109:Acetylcholine; D011188:Potassium; D002118:Calcium; D013324:Strontium